Oryzon Genomics S.A. (FRA:ORN)
3.180
+0.045 (1.44%)
At close: Dec 5, 2025
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €252.33 million as of December 5, 2025. Its market cap has increased by 165.85% in one year.
Market Cap
252.33M
Enterprise Value
239.34M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.18
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 252.33M, an increase of 106.83%. That is a compound annual growth rate of 7.55%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |